Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 1/20 | 0.45 |
| ▸ | PTGDR2 | Q9Y5Y4 | 5/20 | 0.44 |
| ▸ | FFAR1 | O14842 | 9/20 | 0.44 |
| ▸ | PPARD | Q03181 | 5/20 | 0.44 |
| ▸ | PPARA | Q07869 | 4/20 | 0.44 |
| ▸ | PPARG | P37231 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | PTGDR | Q13258 | 1/20 | 0.43 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6540961 | 0.87 | APEX1 (0.49) | PTPN1PTGDR2FFAR1PPARDPPARA | |
| SCHEMBL6540959 | 0.86 | TDP1 (0.48) | PTPN1PTGDR2ALDH1A1 | |
| SCHEMBL6553968 | 0.84 | CYP4F2 (0.42) | — | |
| SCHEMBL6541353 | 0.83 | HTR6 (0.51) | PTPN1PTGDR2FFAR1PPARDPPARA | |
| SCHEMBL6541794 | 0.82 | PTPN1 (0.44) | PTPN1PTGDR2FFAR1PPARDPPARA | |
| SCHEMBL6553965 | 0.82 | NAMPT (0.37) | PPARAPPARG | |
| SCHEMBL6539185 | 0.82 | ALDH1A1 (0.68) | ALDH1A1 | |
| SCHEMBL6540974 | 0.81 | ALDH1A1 (0.52) | ALDH1A1 | |
| SCHEMBL6540022 | 0.77 | ADRB3 (0.68) | — | |
| SCHEMBL6540027 | 0.77 | ADRB3 (0.68) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040138462-A1 | Aminoalcohol derivatives | ASTELLAS PHARMA INC. (JP) | 2004-07-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040138462-A1 | Aminoalcohol derivatives | BPHL, FANCD2, HRH2 | PTPN1 4443/4885PTGDR2 300/4885FFAR1 282/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.